Literature DB >> 21848628

Exposure to hookworms in patients with Crohn's disease: a case-control study.

J Kabeerdoss1, S Pugazhendhi, V Subramanian, H J Binder, B S Ramakrishna.   

Abstract

BACKGROUND: Helminths have been used to inhibit intestinal inflammation in patients with Crohn's disease. AIM: This study was undertaken to determine if there is a protective association of prior hookworm infection with Crohn's disease, in a region where there is epidemiological transition from parasitic and infectious diseases to increased auto-inflammatory diseases.
METHODS: Hookworm exposure was assessed by peripheral blood mononuclear cell (PBMC) activation by hookworm antigens in 78 patients with Crohn's disease and 75 healthy control participants. The change in proportion of T cells exhibiting CD69 after exposure to crude hookworm antigens was measured. Interferon-γ ELISPOT response to a panel of six recombinant hookworm antigens was analysed.
RESULTS: Patients with Crohn's disease were more often from an urban background (P=0.005) compared to controls, while their socioeconomic status was not significantly different. T cell activation (increase in CD3(+) CD69(+) population) by hookworm antigen was significantly higher in controls compared to Crohn's disease patients (P=0.017), while activation by the nonspecific mitogen phytohemagglutinin was similar in both groups. Circulating T memory cells (CD3(+) CD45RO(+)) after exposure to hookworm antigens were not significantly different between the two groups. Mirroring these changes, interferon-γ ELISPOT responses to hookworm antigens were seen in 36 of 75 controls compared to 20 of 78 Crohn's disease patients (Fisher's exact P=0.005). Multivariate analysis indicated that CD3CD69 shifts (P=0.019), ELISPOT reactivity (P=0.039) and place of residence (P=0.024) were all independently associated with Crohn's disease.
CONCLUSION: The inverse association between Crohn's disease and hookworm antigen reactivity is consistent with the hygiene hypothesis, but requires further exploration.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848628     DOI: 10.1111/j.1365-2036.2011.04824.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

Review 1.  Do We Need Worms to Promote Immune Health?

Authors:  Joel V Weinstock
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

2.  Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis.

Authors:  Long Hang; Arthur M Blum; Tommy Setiawan; Joseph P Urban; Korynn M Stoyanoff; Joel V Weinstock
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

3.  Have worms lost their luster?

Authors:  Joel V Weinstock
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

Review 4.  Where are we on worms?

Authors:  David E Elliott; Joel V Weinstock
Journal:  Curr Opin Gastroenterol       Date:  2012-11       Impact factor: 3.287

Review 5.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 6.  Translatability of helminth therapy in inflammatory bowel diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  Int J Parasitol       Date:  2012-11-21       Impact factor: 3.981

Review 7.  Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities.

Authors:  Jason M Norman; Scott A Handley; Herbert W Virgin
Journal:  Gastroenterology       Date:  2014-02-05       Impact factor: 22.682

8.  Structural basis for the immunomodulatory function of cysteine protease inhibitor from human roundworm Ascaris lumbricoides.

Authors:  Guoqiang Mei; Jianmei Dong; Zhaotao Li; Sanling Liu; Yunfeng Liu; Mingze Sun; Guiyun Liu; Zhong Su; Jinsong Liu
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

Review 9.  Potential treatment of inflammatory bowel disease: a review of helminths therapy.

Authors:  Niloofar Taghipour; Hamid Asadzadeh Aghdaei; Ali Haghighi; Nariman Mossafa; Seyyed Javad Seyyed Tabaei; Mohammad Rostami-Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

10.  An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment.

Authors:  Niloofar Taghipour; Mahsa Molaei; Nariman Mosaffa; Mohammad Rostami-Nejad; Hamid Asadzadeh Aghdaei; Ali Anissian; Pedram Azimzadeh; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.